Vaccinations

University of Oxford launches first human aerosol TB vaccine trial

The University of Oxford has commenced a new clinical trial called TB-45, which will test the safety of a new tuberculosis (TB) vaccine.

ICE detention centres withheld vaccines from child migrants

Over 12 US Immigration and Customs Enforcement (ICE) detention centres had multiple outbreaks of infectious disease - due to withholding vaccines for adult and child migrants.

When is the UK COVID-19 vaccine going to be ready?

While AstraZeneca and Oxford University continue to work on a UK COVID-19 vaccine, what about the rest of the world?

Research finds hydroxychloroquine does not work against COVID-19

A study published in Clinical Infectious Diseases found that hydroxychloroquine did not work to protect healthcare professionals from COVID-19.

The ‘herd immunity’ strategy for COVID-19 is dangerous and unfeasible 

Professor Martin Michaelis and Dr Mark Wass of University of Kent’s School of Biosciences, explain why a herd immunity approach to COVID-19 would include great risk, potentially many deaths, and may simply not work.

What are Europe’s health policy priorities going forward?

Open Access Government explores the European Commission’s Department of Health and Food Safety’s response to the COVID-19 crisis and charts their next steps towards a vaccine for every European citizen.

COVID-19 antibodies decline significantly one month after discharge

A new study has revealed that COVID-19 antibodies fade after only a month, which could be a devastating blow in the global race to find a vaccine.

Russia approves COVID-19 vaccine before completing trials

Russia is the first country to announce the approval of a COVID-19 vaccine, without completing clinical trials.

The challenges of COVID-19 human infection trials

Professor Martin Michaelis and Dr Mark Wass, School of Biosciences at University of Kent, explain the long and infamous history of human infection trials.

Covid-19: Could a vaccine be available by September?

Scientists from the University of Oxford, joint with AstraZeneca, are hopeful that their vaccine, to protect against Covid-19, could be available as early as September.

Uptake of existing vaccines will help support health systems from COVID-19 pressures

The Immunisation For All Ages group discusses the importance of protecting vaccine budgets and immunisation infrastructure, even amidst COVID-19.

Japan and EU work on strategic partnership for COVID-19 pandemic

President von der Leyen, Council President Charles Michel and Prime Minister of Japan Shinzō Abe, discussed the global response to the COVID-19 pandemic.

Economic and scientific experts discuss EU response to COVID-19

Here we summarise a discussion with experts on the EU response to COVID-19 and the role of Horizon Europe in this pandemic.

Vaccine misinformation is more likely on social media

Researchers have found that people who use social media for news are more likely to experience vaccine misinformation.

Government pledges £20 million to develop new coronavirus vaccine

The Government has today pledged £20 million to develop a new coronavirus vaccine following concerns over the ongoing outbreak in China.

The pharmaceutical industry in Europe

Here, we focus on some of the key issues facing the pharmaceutical industry throughout Europe.

UK aid to help vaccinate 400 million children against polio

International Development Secretary Alok Sharma has pledged new UK aid support to help vaccinate more than 400 million children a year against polio.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders